Person:
Clear filters
Thursday, October 26, 2017
Morning
07:55 a.m. - 09:45 a.m.
SMSNA Basic Science Symposium: Inflammation in Injury and RepairLocation: Salon C+DModerators: Tom Lue, MD & Carol Podlasek, PhD
07:55 a.m. - 08:00 a.m.
Opening Remarks
Opening Remarks
Kelvin Davies, BSc, MSc, PhD
08:00 a.m. - 08:25 a.m.
Innate Immunity and Sexual Dysfunction
Innate Immunity and Sexual Dysfunction
Clinton Webb, PhD
08:25 a.m. - 08:55 a.m.
Inflammation in Radiation Induced Sexual Dysfunction
Inflammation in Radiation Induced Sexual Dysfunction
Johanna Hannan, PhD
08:55 a.m. - 09:20 a.m.
Unwinding Fibrosis in Peyronie’s Disease
Unwinding Fibrosis in Peyronie’s Disease
Alexander Pastuszak, MD, PhD
09:20 a.m. - 09:45 a.m.
Innovation in Sexual Dysfunction – Future Therapies
Innovation in Sexual Dysfunction – Future Therapies
Justin La Favor, PhD
08:00 a.m. - 10:00 a.m.
SMSNA/ Chinese Andrology/ Societies Program, Part ILocation: Salon A+BModerators: Chunhua Deng, MD, Joshua Gonzalez, MD & Nikolai Sopko, MD, PhD
08:00 a.m. - 08:05 a.m.
Welcome
Welcome
Run Wang, MD, FACS & Hui Jiang, MD
08:05 a.m. - 08:20 a.m.
Starting a Clinical Practice: The Most Important Things I Have Learned Since Fellowship and Things I Wish I Had Known
Starting a Clinical Practice: The Most Important Things I Have Learned Since Fellowship and Things I Wish I Had Known
Lawrence Jenkins, MD, MBA
08:20 a.m. - 08:30 a.m.
The Fffect of Kid' Return on Female Sexual Function during the Summer Holiday
The Fffect of Kid' Return on Female Sexual Function during the Summer Holiday
Yan Zhang, MD
08:30 a.m. - 08:40 a.m.
Chinese Sexual Habit: An Internet Based Large Data Study
Chinese Sexual Habit: An Internet Based Large Data Study
Haocheng Lin, MD
08:40 a.m. - 08:50 a.m.
The Clinical Application of Cavernosometry and Cavernosography in Venous Erectile Dysfunction
The Clinical Application of Cavernosometry and Cavernosography in Venous Erectile Dysfunction
Tao Song, MD
08:50 a.m. - 09:10 a.m.
How to Grow your Practice on Social Media
How to Grow your Practice on Social Media
Jamin Brahmbhatt, MD
09:10 a.m. - 09:25 a.m.
Consecutive Nightly Recordings for the Accurate Monitoring of Nocturnal Erections, Is This Required?
Consecutive Nightly Recordings for the Accurate Monitoring of Nocturnal Erections, Is This Required?
Yan Zhang, MD
09:25 a.m. - 09:40 a.m.
Herbal Therapies in Sexual Medicine – Is there a role?
Herbal Therapies in Sexual Medicine – Is there a role?
Joshua Gonzalez, MD
09:40 a.m. - 10:00 a.m.
State of the Art: Highlighting Chinese Innovations in Sexual Medicine
State of the Art: Highlighting Chinese Innovations in Sexual Medicine
Tao Jiang, MD
08:50 a.m. - 01:00 p.m.
APN/PA SymposiumLocation: Conference Room 3+4Moderator: Jeffrey Albaugh, PhD, APRN, CUCNS
08:50 a.m. - 09:00 a.m.
Welcome / Introduction
Welcome / Introduction
Jeffrey Albaugh, PhD, APRN, CUCNS
09:00 a.m. - 10:00 a.m.
Establishing and Running an ED Clinic as an APN/PA
Establishing and Running an ED Clinic as an APN/PA
Penny K. Jensen, DNP, FNP, FAANP & Kenneth Mitchell, MPAS, PA-C
10:00 a.m. - 10:40 a.m.
Evaluating and Managing Genital/Scrotal Pain
Evaluating and Managing Genital/Scrotal Pain
Laurence Levine, MD, FACS
10:40 a.m. - 11:20 a.m.
Penile Rehabilitation Panel Discussion
Penile Rehabilitation Panel Discussion
Jeffrey Albaugh, PhD, APRN, CUCNS & John Mulhall, MD
11:20 a.m. - 12:00 p.m.
Transgender Care
Transgender Care
Charles Moser, PhD, MD & Tami Rowen, MD, MS, FACOG
12:00 p.m. - 01:00 p.m.
APN/PA Networking Lunch
APN/PA Networking Lunch
09:45 a.m. - 10:15 a.m.
SMSNA Basic Science Symposium: Impact of Urologic Surgery on Female Sexual FunctionLocation: Salon C+DModerators: Kelvin Davies, BSc, MSc, PhD & Nestor Gonzalez-Cadavid , PhD
09:45 a.m. - 10:00 a.m.
Basic Science
Basic Science
Michael Adams, PhD
10:00 a.m. - 10:15 a.m.
Clinical Implications
Clinical Implications
Irwin Goldstein, MD
10:00 a.m. - 10:30 a.m.
Coffee BreakLocation: Foyer
10:30 a.m. - 11:30 a.m.
SMSNA Basic Science Symposium: Keynote SpeakerLocation: Salon C+DModerators: Trinity Bivalacqua, MD, PhD & Run Wang, MD, FACS
10:30 a.m. - 11:30 a.m.
The Lasting Consequences of Early Life Stress or Insult
The Lasting Consequences of Early Life Stress or Insult
Julie Carlsten Christianson, PhD
10:30 a.m. - 12:00 p.m.
SMSNA/ Chinese Andrology/ Societies Program, Part II - Lifestyle Factors and Sexual DysfunctionLocation: Salon A+BModerators: Amy Guise, MD, Yutian Dai, MD & Jian Cai, MD
10:30 a.m. - 10:45 a.m.
Surgical Frailty and Prosthetic Health
Surgical Frailty and Prosthetic Health
Jay Simhan, MD
10:45 a.m. - 11:00 a.m.
The Management of ED in China
The Management of ED in China
Qiang Dong, MD
11:00 a.m. - 11:15 a.m.
Impact of Comorbid Disease Management and Medication Reduction on Sexual Function
Impact of Comorbid Disease Management and Medication Reduction on Sexual Function
William Brant, MD
11:15 a.m. - 11:30 a.m.
Eastern Approach to Premature Ejaculation
Eastern Approach to Premature Ejaculation
Yun Chen, MD
11:30 a.m. - 11:45 a.m.
Exercise and Sexual Function
Exercise and Sexual Function
Seth Cohen, MD, MPH
11:45 a.m. - 12:00 p.m.
Seminal Dysbiosis is Associated with Low Seminal Quality in Varicocele Patients
Seminal Dysbiosis is Associated with Low Seminal Quality in Varicocele Patients
Xiadong Jin, MD, PhD
11:30 a.m. - 12:15 p.m.
SMSNA Basic Science Symposium: 3 Minute Thesis Competition for TraineesLocation: Salon C+DModerators: Johanna Hannan, PhD & Alexander Pastuszak, MD, PhD
Afternoon
12:15 p.m. - 01:00 p.m.
SMSNA Basic Science Symposium: Lunch with the ExpertsLocation: Salon F
01:00 p.m. - 01:30 p.m.
Opening and WelcomeLocation: Salon E
01:00 p.m. - 01:10 p.m.
Welcome and SMSNA Update
Welcome and SMSNA Update
Run Wang, MD, FACS
01:10 p.m. - 01:20 p.m.
ISSM Update
ISSM Update
Luca Incrocci, MD, PhD
01:20 p.m. - 01:30 p.m.
Program Overview
Program Overview
Landon Trost, MD
01:30 p.m. - 02:30 p.m.
CJK Session 1: Basic Research and New Strategy for ED TreatmentLocation: Salon A+BModerators: Tae Young Ahn, MD, Trinity Bivalacqua, MD, PhD & Zhong-Cheng Xin, MD, PhD
01:30 p.m. - 01:35 p.m.
Opening Remarks
Opening Remarks
Yoskikazu Sato, MD, PhD & Daeyul Yang, MD
01:35 p.m. - 01:53 p.m.
Next Generation Therapies for Erectile Dysfunction: Chemokine Based Therapeutics
Next Generation Therapies for Erectile Dysfunction: Chemokine Based Therapeutics
Trinity Bivalacqua, MD, PhD
01:53 p.m. - 02:11 p.m.
New Strategy of Prevention and Treatment Diabetic ED
New Strategy of Prevention and Treatment Diabetic ED
Yutian Dai, MD
02:11 p.m. - 02:26 p.m.
M1 Macrophages Are Predominantly Recruited to the Major Pelvic Ganglion of the Rat Following Cavernous Nerve Injury
M1 Macrophages Are Predominantly Recruited to the Major Pelvic Ganglion of the Rat Following Cavernous Nerve Injury
Hotaka Matsui, MD
01:30 p.m. - 03:30 p.m.
BPH, Incontinence, ReconstructionLocation: Salon EModerators: Gregory Broderick, MD & Billy Cordon, MD
01:30 p.m. - 01:45 p.m.
Updates in BPH, Incontinence, and Reconstruction – Most Noteworthy Literature from 2016-2017
Updates in BPH, Incontinence, and Reconstruction – Most Noteworthy Literature from 2016-2017
Seth Cohen, MD, MPH
01:45 p.m. - 01:55 p.m.
#001: Urinary and Sexual Function in 411 Obese Hypogonadal Men with and without Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office
#001: Urinary and Sexual Function in 411 Obese Hypogonadal Men with and without Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office
A. Haider
01:55 p.m. - 02:05 p.m.
#002: Simulated Over-the-counter use of Tamsulosin by Men with Urinary Symptoms
#002: Simulated Over-the-counter use of Tamsulosin by Men with Urinary Symptoms
C.G. Roehrborn
02:05 p.m. - 02:15 p.m.
#003: Effects of Udenafil 75mg (Zydena®) Administration on Post-Micturition Dribbling (PMD) in Men: A Prospective, Multi-Centered, Double-Blinded, Placebo-Controlled, and Randomized Clinical Study
#003: Effects of Udenafil 75mg (Zydena®) Administration on Post-Micturition Dribbling (PMD) in Men: A Prospective, Multi-Centered, Double-Blinded, Placebo-Controlled, and Randomized Clinical Study
K. Ko
02:15 p.m. - 02:50 p.m.
A Practical Guide on Office-based, Sexual Function Preserving BPH Therapies
A Practical Guide on Office-based, Sexual Function Preserving BPH Therapies
Rafael Carrion, MD & Nikhil Gupta, MD
02:50 p.m. - 03:00 p.m.
#004: Convective Radiofrequency Thermal Therapy (Rezum®) Effectively Treats Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia Regardless of Obesity while Preserving Erectile and Ejaculatory Function
#004: Convective Radiofrequency Thermal Therapy (Rezum®) Effectively Treats Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia Regardless of Obesity while Preserving Erectile and Ejaculatory Function
S. Helo
03:00 p.m. - 03:10 p.m.
#005: Improvement in Sexual Function Associated with Prostatic Artery Embolization (PAE): An Emerging Treatment Option for Men with Symptomatic BPH
#005: Improvement in Sexual Function Associated with Prostatic Artery Embolization (PAE): An Emerging Treatment Option for Men with Symptomatic BPH
Bruce Kava, MD
03:10 p.m. - 03:30 p.m.
Surgical Tips / Tricks Learned from over 1300 AUS Procedures
Surgical Tips / Tricks Learned from over 1300 AUS Procedures
Daniel Elliott, MD
01:30 p.m. - 03:30 p.m.
Moderated Poster Session: Androgens, Erectile Dysfunction and Peyronie's DiseaseLocation: Salon C+DModerators: Arthur Burnett, MD & Edward Gheiler, MD, FACS
01:30 p.m. - 01:35 p.m.
#101: Effect of Nitrosative Stress on Testosterone Production: A Novel Model of Secondary Hypogonadism
#101: Effect of Nitrosative Stress on Testosterone Production: A Novel Model of Secondary Hypogonadism
T. Masterson
01:35 p.m. - 01:40 p.m.
#102: Influence of Genetic Variation in the Androgen Receptor on the Risk of Cardiovascular Disease in Aging Men
#102: Influence of Genetic Variation in the Androgen Receptor on the Risk of Cardiovascular Disease in Aging Men
Tung-Chin (Mike) Hsieh, MD
01:40 p.m. - 01:45 p.m.
#103: Body Iron Stores are Negatively Associated with Serum Testosterone Levels in Men
#103: Body Iron Stores are Negatively Associated with Serum Testosterone Levels in Men
J.S. Gabrielsen
01:45 p.m. - 01:50 p.m.
#104: Low PSA Level In Men Diagnosed With Prostate Cancer Predicts Testosterone Deficiency (TD)
#104: Low PSA Level In Men Diagnosed With Prostate Cancer Predicts Testosterone Deficiency (TD)
H. Levey Bernie
01:50 p.m. - 01:55 p.m.
#105: Improvement of Type 2 Diabetes (T2DM) in Hypogonadal Men receiving Long-term Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office
#105: Improvement of Type 2 Diabetes (T2DM) in Hypogonadal Men receiving Long-term Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office
F. Saad
01:55 p.m. - 02:00 p.m.
#106: Efficacy and Safety of Oral Testosterone Replacement Therapy (LPCN 1021): Analysis of Two Fixed-dose Regimens
#106: Efficacy and Safety of Oral Testosterone Replacement Therapy (LPCN 1021): Analysis of Two Fixed-dose Regimens
C. Welsh
02:00 p.m. - 02:05 p.m.
#107: Preservation of Normal Concentration of Pituitary Gonadotropins Despite Achievement of Normal Serum Testosterone Levels in Hypogonadal Men Treated with 4.5% Nasal Testosterone Gel (Natesto)
#107: Preservation of Normal Concentration of Pituitary Gonadotropins Despite Achievement of Normal Serum Testosterone Levels in Hypogonadal Men Treated with 4.5% Nasal Testosterone Gel (Natesto)
Abraham Morgentaler, MD
02:05 p.m. - 02:10 p.m.
#108: Outcomes of Combination Therapy with Clomiphene and Anastrozole in Subfertile Hypoandrogenic Men
#108: Outcomes of Combination Therapy with Clomiphene and Anastrozole in Subfertile Hypoandrogenic Men
S. Keihani
02:10 p.m. - 02:15 p.m.
#109: Penile Ultrasound: A Cost-effective Test for Pre-treatment Evaluation of Peyronie’s Disease
#109: Penile Ultrasound: A Cost-effective Test for Pre-treatment Evaluation of Peyronie’s Disease
K. Wymer
02:15 p.m. - 02:20 p.m.
#110: No Increased Risk of Autoimmune Conditions in men with Peyronie’s Disease: Analysis of United States Claims Data
#110: No Increased Risk of Autoimmune Conditions in men with Peyronie’s Disease: Analysis of United States Claims Data
Alexander Pastuszak, MD, PhD
02:20 p.m. - 02:25 p.m.
#111: Impact of Hourglass Deformity in Men with Peyronie’s Disease
#111: Impact of Hourglass Deformity in Men with Peyronie’s Disease
M. Alom
02:25 p.m. - 02:30 p.m.
#112: Safety and Efficacy of Collagenase Clostridium Histolyticum in the Treatment of Acute Phase Peyronie's Disease
#112: Safety and Efficacy of Collagenase Clostridium Histolyticum in the Treatment of Acute Phase Peyronie's Disease
H.M.T. Nguyen
02:30 p.m. - 02:35 p.m.
#113: Racial Variations in Response to Intralesional Collagenase Clostridium Histolyticum in Men with Peyronie’s Disease
#113: Racial Variations in Response to Intralesional Collagenase Clostridium Histolyticum in Men with Peyronie’s Disease
H.M.T. Nguyen
02:35 p.m. - 02:40 p.m.
#114: Effect of Collagenase Clostridium Histolyticum on Penile Vascular and Morphological Parameters in Patients with Peyronie's Disease
#114: Effect of Collagenase Clostridium Histolyticum on Penile Vascular and Morphological Parameters in Patients with Peyronie's Disease
L. Diao
02:40 p.m. - 02:45 p.m.
#115: Plaque Calcification Decreases the Success of Collagenase Clostridium Histolyticum Treatment for Peyronie’s Disease
#115: Plaque Calcification Decreases the Success of Collagenase Clostridium Histolyticum Treatment for Peyronie’s Disease
K. Wymer
02:45 p.m. - 02:50 p.m.
#116: Collagenase Clostridium Histolyticum is a Cost-effective Treatment for Peyronie’s Disease in Appropriately Selected Patients
#116: Collagenase Clostridium Histolyticum is a Cost-effective Treatment for Peyronie’s Disease in Appropriately Selected Patients
K. Wymer
02:50 p.m. - 02:55 p.m.
#117: Non-degloving Technique for Peyronie’s Disease with Penile Prosthesis Implantation and Double Dorsal-ventral Patch Graft
#117: Non-degloving Technique for Peyronie’s Disease with Penile Prosthesis Implantation and Double Dorsal-ventral Patch Graft
J. Clavell Hernandez
02:55 p.m. - 03:00 p.m.
#118: The Penile Sensitivity Ratio: A Novel Application of Biothesiometry to Assess Changes in Penile Sensitivity
#118: The Penile Sensitivity Ratio: A Novel Application of Biothesiometry to Assess Changes in Penile Sensitivity
P.N. Tsambarlis
03:00 p.m. - 03:05 p.m.
#119: Measurement of Sexual Function in the Prostate Cancer Patient at One year following insertion of a Penile Prosthesis
#119: Measurement of Sexual Function in the Prostate Cancer Patient at One year following insertion of a Penile Prosthesis
LeRoy Jones, Jr., MD
03:05 p.m. - 03:10 p.m.
#120: Drain Use During Penile Prosthesis Surgery, Results From The PROPPER Study
#120: Drain Use During Penile Prosthesis Surgery, Results From The PROPPER Study
Edward Karpman, MD
03:10 p.m. - 03:15 p.m.
#121: Emerging Data Regarding Fungal Infections of Inflatable Penile Prostheses
#121: Emerging Data Regarding Fungal Infections of Inflatable Penile Prostheses
Martin Gross, MD
03:15 p.m. - 03:25 p.m.
#122: In-vivo Biomechanical Comparison of the Effects of Rear Tip Extenders on Penile Implants
#122: In-vivo Biomechanical Comparison of the Effects of Rear Tip Extenders on Penile Implants
T.S. Hakky
03:25 p.m. - 03:30 p.m.
#123: Global Prevalence, Patient Profiles, and Health Outcomes of Erectile Dysfunction (ED) among 40-70 Year-old Men
#123: Global Prevalence, Patient Profiles, and Health Outcomes of Erectile Dysfunction (ED) among 40-70 Year-old Men
Irwin Goldstein, MD
02:30 p.m. - 03:30 p.m.
CJK Session 2: Topics from AsiaLocation: Salon A+BModerators: Mikio Namiki, MD, PhD, Nam Cheol Park, MD, PhD & Hossein Sadeghi-Nejad, MD, FACS
02:30 p.m. - 02:42 p.m.
Guo's Single-Armed Suture Technique for Microsurgical Vasoepididymostomy
Guo's Single-Armed Suture Technique for Microsurgical Vasoepididymostomy
Yiming Yuan, MD
02:42 p.m. - 02:54 p.m.
Autologous Dermal Grafting for Peyronie’s Disease and Pelvic Organ Prolapse
Autologous Dermal Grafting for Peyronie’s Disease and Pelvic Organ Prolapse
Koichi Nagao, MD, PhD
02:54 p.m. - 03:06 p.m.
Female Sexual Dysfunction: Asian Perspectives
Female Sexual Dysfunction: Asian Perspectives
Kwangsung Park, MD, PhD
03:06 p.m. - 03:18 p.m.
HIFU for Vaginal Tightening
HIFU for Vaginal Tightening
Yuki Sekiguchi, MD, PhD
03:18 p.m. - 03:30 p.m.
New Device : Low Intensity Pulsed Untrsound(LIUPS) on ED
New Device : Low Intensity Pulsed Untrsound(LIUPS) on ED
Zhong-Cheng Xin, MD, PhD
03:30 p.m. - 04:00 p.m.
Coffee BreakLocation: Salon H+I
04:00 p.m. - 05:10 p.m.
CJK Session 3: How to Manage Non-responders to PDE5 InhibitorsLocation: Salon A+BModerators: Koichi Nagao, MD, PhD & Daeyul Yang, MD
04:00 p.m. - 04:15 p.m.
Incidence, Causes and Predictors of PDE5 of Non-responders to PDE5 Inhibitors
Incidence, Causes and Predictors of PDE5 of Non-responders to PDE5 Inhibitors
Sang Chul Kam, MD
04:15 p.m. - 04:30 p.m.
Role of Daily Treatment of PDE5 Inhibitors of Non-responders to PDE5 Inhibitors
Role of Daily Treatment of PDE5 Inhibitors of Non-responders to PDE5 Inhibitors
Jin Wook Kim, MD, PhD
04:30 p.m. - 04:45 p.m.
Role of Testosterone Replacement Therapy of Non-responders to PDE5 Inhibitors
Role of Testosterone Replacement Therapy of Non-responders to PDE5 Inhibitors
Won Ki Lee, MD, PhD
04:45 p.m. - 05:10 p.m.
Panel Discussion with Case Presentation
Panel Discussion with Case Presentation
Kweon Sik Min, MD, Heung Jae Park, MD, Hyun Jun Park, MD, PhD & Yoskikazu Sato, MD, PhD
04:00 p.m. - 05:30 p.m.
Moderated Poster Session: Peyronie’s Disease and AndrogensLocation: Salon EModerators: Bruce Kava, MD, Peter Stahl, MD & Faysal Yafi, MD, FRCSC
04:00 p.m. - 04:05 p.m.
#124: Pharmacokinetic Comparison of Two Fixed-dose Regimens of an Oral Testosterone Replacement Therapy
#124: Pharmacokinetic Comparison of Two Fixed-dose Regimens of an Oral Testosterone Replacement Therapy
J. Kaminetsky
04:10 p.m. - 04:15 p.m.
#126: Impact of a Patient Support Program for AndroGel 1.62% Topical Testosterone Gel on Adherence among Males with Primary or Secondary Hypogonadism
#126: Impact of a Patient Support Program for AndroGel 1.62% Topical Testosterone Gel on Adherence among Males with Primary or Secondary Hypogonadism
Z. Hepp
04:15 p.m. - 04:20 p.m.
#127: Testosterone Therapy leads to Sustained Weight Loss, Improved Erectile Function and Reduction of MACE in Hypogonadal Men in a 10-year Real-life Registry
#127: Testosterone Therapy leads to Sustained Weight Loss, Improved Erectile Function and Reduction of MACE in Hypogonadal Men in a 10-year Real-life Registry
F. Saad
04:20 p.m. - 04:25 p.m.
#128: Sex Hormone Binding Globulin Independently Predicts Oligospermia in Male Fertility Patients
#128: Sex Hormone Binding Globulin Independently Predicts Oligospermia in Male Fertility Patients
J. Ring
04:25 p.m. - 04:30 p.m.
#129: Testosterone Use and its Associated Increased Aggression
#129: Testosterone Use and its Associated Increased Aggression
N. Thirumavalavan
04:30 p.m. - 04:35 p.m.
#130: Relationship between Testosterone and Prostatitis: Results from the REDUCE study
#130: Relationship between Testosterone and Prostatitis: Results from the REDUCE study
A.S. Herati
04:35 p.m. - 04:40 p.m.
#131: Prostate Cancer Incidence and Severity in Testosterone-treated vs. Untreated Hypogonadal Men: Real-life Experience from more than 5500 Patients Years
#131: Prostate Cancer Incidence and Severity in Testosterone-treated vs. Untreated Hypogonadal Men: Real-life Experience from more than 5500 Patients Years
A. Haider
04:40 p.m. - 04:45 p.m.
#132: Initial Experience with Testosterone Therapy in Selected Men with Advanced or Metastatic Prostate Cancer
#132: Initial Experience with Testosterone Therapy in Selected Men with Advanced or Metastatic Prostate Cancer
Abraham Morgentaler, MD
04:45 p.m. - 04:50 p.m.
#133: Changes in Sexual Function, Relationship Satisfaction, and Quality of Life in Men with Untreated Peyronie’s Disease
#133: Changes in Sexual Function, Relationship Satisfaction, and Quality of Life in Men with Untreated Peyronie’s Disease
R. Bole
04:50 p.m. - 04:55 p.m.
#134: Daily Tadalafil Therapy: A New Treatment Option for Peyronie’s Disease?
#134: Daily Tadalafil Therapy: A New Treatment Option for Peyronie’s Disease?
Hyun Jun Park, MD, PhD
04:55 p.m. - 05:00 p.m.
#135: Intralesional Collagenase Clostridium Histolyticum causes meaningful improvement in most men with Peyronie’s Disease: The results of a multi-institutional analysis
#135: Intralesional Collagenase Clostridium Histolyticum causes meaningful improvement in most men with Peyronie’s Disease: The results of a multi-institutional analysis
K.J. DeLay
05:00 p.m. - 05:05 p.m.
#136: Collagenase Clostridium Histolyticum for the Treatment of Ventral Penile Curvature - Interim Analysis of Objective Outcomes
#136: Collagenase Clostridium Histolyticum for the Treatment of Ventral Penile Curvature - Interim Analysis of Objective Outcomes
K. Wymer
05:05 p.m. - 05:10 p.m.
#137: Safety of Second Round of Eight Injections of Collagenase Clostridium Histolyticum (CCH) in the Treatment of Peyronie’s Disease
#137: Safety of Second Round of Eight Injections of Collagenase Clostridium Histolyticum (CCH) in the Treatment of Peyronie’s Disease
C. Bryson
05:10 p.m. - 05:15 p.m.
#138: Successful Treatment of Residual Curvature in Peyronie’s Disease in Men Previously Treated with Intralesional Clostridium Collagenase Histolyticum
#138: Successful Treatment of Residual Curvature in Peyronie’s Disease in Men Previously Treated with Intralesional Clostridium Collagenase Histolyticum
K.J. DeLay
05:15 p.m. - 05:20 p.m.
#139: Comparison of Standard Collagenase Clostridium Histolyticum (CCH) Protocol and Modified Interferon 2alpha2b (IFN) Protocol for the Management of Peyronie’s Disease (PD) at 2 large Health Care Organizations
#139: Comparison of Standard Collagenase Clostridium Histolyticum (CCH) Protocol and Modified Interferon 2alpha2b (IFN) Protocol for the Management of Peyronie’s Disease (PD) at 2 large Health Care Organizations
Rachel Rubin, MD
05:20 p.m. - 05:25 p.m.
#140: Multi-institutional Prospective Analysis of Intralesional Injection of Collagenase Clostridium Histolyticum, Tunical Plication and Partial Plaque Excision and Grafting for the Management of Peyronie’s Disease
#140: Multi-institutional Prospective Analysis of Intralesional Injection of Collagenase Clostridium Histolyticum, Tunical Plication and Partial Plaque Excision and Grafting for the Management of Peyronie’s Disease
Faysal Yafi, MD, FRCSC
05:25 p.m. - 05:30 p.m.
#141: Use and Satisfaction in Patients with Peyronies Disease who have Undergone Penile Prosthesis: 1 and 2 Year Followup from the PROPPER Registry
#141: Use and Satisfaction in Patients with Peyronies Disease who have Undergone Penile Prosthesis: 1 and 2 Year Followup from the PROPPER Registry
William Brant, MD
04:00 p.m. - 05:30 p.m.
Moderated Poster Session: Female Sexual Function / Mental Health / Transgender HealthLocation: Salon C+DModerators: Sue Goldstein, CCRC, CSE, IF & Daniela Wittmann, PhD, LMSW
04:00 p.m. - 04:05 p.m.
#142: Does Sexual Abuse have a Different Effect Depending on the Sexual Orientation?
#142: Does Sexual Abuse have a Different Effect Depending on the Sexual Orientation?
F. Ramirez
04:10 p.m. - 04:15 p.m.
#144: Shift Workers with Shift Work Sleep Disorder are at Increased Risk For Depressive Symptoms
#144: Shift Workers with Shift Work Sleep Disorder are at Increased Risk For Depressive Symptoms
D.J. Mazur
04:15 p.m. - 04:20 p.m.
#145: Evaluating Urology Residency Program Websites for Female Sexual Dysfunction Content: Does it Exist?
#145: Evaluating Urology Residency Program Websites for Female Sexual Dysfunction Content: Does it Exist?
David Shin, MD
04:20 p.m. - 04:25 p.m.
#146: Standardization of Vulvoscopy: A Step-Wise Approach
#146: Standardization of Vulvoscopy: A Step-Wise Approach
A. Winter
04:25 p.m. - 04:30 p.m.
#147: Prospective Vulvoscopic Analysis of Changes to the Vulva, Vestibule, and Vagina in Women with Genitourinary Syndrome of Menopause (GSM) taking Ospemifene
#147: Prospective Vulvoscopic Analysis of Changes to the Vulva, Vestibule, and Vagina in Women with Genitourinary Syndrome of Menopause (GSM) taking Ospemifene
A. Winter
04:30 p.m. - 04:35 p.m.
#148: Retrospective Study of the Prevalence and Risk Factors of Clitoral Adhesions: Why Women’s Health Providers Should Routinely Examine the Glans Clitoris
#148: Retrospective Study of the Prevalence and Risk Factors of Clitoral Adhesions: Why Women’s Health Providers Should Routinely Examine the Glans Clitoris
E.D. Biewenga
04:35 p.m. - 04:40 p.m.
#149: Extent of Female Partner Sexual Function Improvement in Female Partners of Men With Peyronie’s Disease Who Received Collagenase Clostridium Histolyticum
#149: Extent of Female Partner Sexual Function Improvement in Female Partners of Men With Peyronie’s Disease Who Received Collagenase Clostridium Histolyticum
Irwin Goldstein, MD
04:40 p.m. - 04:45 p.m.
#150: BP101 New Molecule for HSDD Treatment - Results of Proof-of-concept Phase 2a Study
#150: BP101 New Molecule for HSDD Treatment - Results of Proof-of-concept Phase 2a Study
D. Nemenov
04:45 p.m. - 04:50 p.m.
#151: Use of Autologous Dermal Tissue Preserves Sexual Function after Pelvic Organ Prolapse Surgery
#151: Use of Autologous Dermal Tissue Preserves Sexual Function after Pelvic Organ Prolapse Surgery
Koichi Nagao, MD, PhD
04:50 p.m. - 04:55 p.m.
#153: Fiera After Midlife Experience: The FAME Case Series
#153: Fiera After Midlife Experience: The FAME Case Series
Leah Millheiser, MD
04:55 p.m. - 05:00 p.m.
#154: The Impact of Fiera + Remote on Female Sexual Function, Relationship Satisfaction, and Sexual Quality of Life
#154: The Impact of Fiera + Remote on Female Sexual Function, Relationship Satisfaction, and Sexual Quality of Life
Leah Millheiser, MD
05:00 p.m. - 05:05 p.m.
#155: Barriers to Post-Transgender Surgery Care In the Federal Prison System
#155: Barriers to Post-Transgender Surgery Care In the Federal Prison System
M. Garcia
05:05 p.m. - 05:10 p.m.
#156: Fresh Human Cadaver Vaginoplasty Surgical Prosections to Guide Surgical Technique, Post-Operative Care, and the Design of a Novel Neovaginal Dilator and Douching Device
#156: Fresh Human Cadaver Vaginoplasty Surgical Prosections to Guide Surgical Technique, Post-Operative Care, and the Design of a Novel Neovaginal Dilator and Douching Device
M. Garcia
05:10 p.m. - 05:15 p.m.
#157: Common and Uncommon Complications after M to F Gender Affirming Genital Surgery with Vaginoplasty
#157: Common and Uncommon Complications after M to F Gender Affirming Genital Surgery with Vaginoplasty
M. Garcia
05:15 p.m. - 05:20 p.m.
#158: Development, Validation, and Results from a Novel Inventory to Assess and Compare Gender Dysphoria Before and After Genital Gender Affirming Surgery
#158: Development, Validation, and Results from a Novel Inventory to Assess and Compare Gender Dysphoria Before and After Genital Gender Affirming Surgery
M. Garcia
05:20 p.m. - 05:25 p.m.
#159: Effects of Cross-sex Hormone Therapy on Laboratory Values in Female-to-male Transgender Patients
#159: Effects of Cross-sex Hormone Therapy on Laboratory Values in Female-to-male Transgender Patients
E. Gao
Evening
05:30 p.m. - 07:00 p.m.
Welcome ReceptionLocation: Salon H+I
Friday, October 27, 2017
Morning
07:00 a.m. - 08:00 a.m.
Industry Sponsored Breakfast SymposiumLocation: Salon F
show program08:00 a.m. - 10:00 a.m.
SurgicalLocation: Salon EModerators: Gerald Brock, MD & Hossein Sadeghi-Nejad, MD, FACS
08:00 a.m. - 08:20 a.m.
Ethical Dilemmas in Sexual Medicine: Sex Offenders and Other Scenarios
Ethical Dilemmas in Sexual Medicine: Sex Offenders and Other Scenarios
Helena Christine
08:20 a.m. - 08:35 a.m.
The Top 5 (Surgical) Things I Wish I Would Have Known Earlier in My Career - Tips and Tricks, Disasters, and Lessons Learned: Penile Prosthesis Surgery
The Top 5 (Surgical) Things I Wish I Would Have Known Earlier in My Career - Tips and Tricks, Disasters, and Lessons Learned: Penile Prosthesis Surgery
Steven Wilson, MD
08:35 a.m. - 08:50 a.m.
The Top 5 (Surgical) Things I Wish I Would Have Known Earlier in My Career - Tips and Tricks, Disasters, and Lessons Learned: Peyronie’s Disease Surgery
The Top 5 (Surgical) Things I Wish I Would Have Known Earlier in My Career - Tips and Tricks, Disasters, and Lessons Learned: Peyronie’s Disease Surgery
Tom Lue, MD
08:50 a.m. - 09:00 a.m.
A “How-to Video Guide” for Novel Surgical Approaches: Collage Fleece
A “How-to Video Guide” for Novel Surgical Approaches: Collage Fleece
Georgios Hatzichristodoulou, MD, FEBU, FECSM
09:00 a.m. - 09:10 a.m.
A “How-to Video Guide” for Novel Surgical Approaches: Office Based Andrologic Procedures
A “How-to Video Guide” for Novel Surgical Approaches: Office Based Andrologic Procedures
Landon Trost, MD
09:10 a.m. - 09:20 a.m.
A “How-to Video Guide” for Novel Surgical Approaches: Impending Erosion
A “How-to Video Guide” for Novel Surgical Approaches: Impending Erosion
Steven Wilson, MD
09:20 a.m. - 09:35 a.m.
A “How-to Video Guide” for Novel Surgical Approaches: Discussion
A “How-to Video Guide” for Novel Surgical Approaches: Discussion
09:35 a.m. - 10:00 a.m.
Soapbox Corner: What You Do, and Why Everyone else Should be Doing It – An Interactive Audience Participation Session
Soapbox Corner: What You Do, and Why Everyone else Should be Doing It – An Interactive Audience Participation Session
Gerald Brock, MD (moderator), Brian Christine, MD, Martin Gross, MD, Andrew Kramer, MD, Laurence Levine, MD, FACS & Thomas Walsh, MD, MS
10:00 a.m. - 10:30 a.m.
Coffee BreakLocation: Salon H+I
10:30 a.m. - 11:30 a.m.
ESSM Symposium - Difficult Cases in Sexual MedicineLocation: Salon EModerator: Hartmut Porst, MD
10:30 a.m. - 10:45 a.m.
Management of Penile Prosthesis Complications
Management of Penile Prosthesis Complications
Carlo Bettocchi, MD
10:45 a.m. - 11:00 a.m.
Surgical Management Algorithm in Complex Peyronie´s Disease Cases
Surgical Management Algorithm in Complex Peyronie´s Disease Cases
Juan Ignacio Martinez-Salamanca, MD, PhD
11:00 a.m. - 11:15 a.m.
Significance of Penile Extracorporeal Shockwave Therapy (ESWT) in the Treatment of Difficult Cases in Sexual Medicine
Significance of Penile Extracorporeal Shockwave Therapy (ESWT) in the Treatment of Difficult Cases in Sexual Medicine
Hartmut Porst, MD
11:15 a.m. - 11:30 a.m.
Q&A
Q&A
10:30 a.m. - 12:00 p.m.
Erectile Dysfunction MedicalLocation: Salon C+DModerators: Nelson Bennett, Jr, MD, Hui Jiang, MD & David Shin, MD
10:30 a.m. - 10:50 a.m.
Updates in Medical Management of ED – Most Noteworthy Literature from 2016-2017
Updates in Medical Management of ED – Most Noteworthy Literature from 2016-2017
Faysal Yafi, MD, FRCSC
10:50 a.m. - 11:10 a.m.
4th Annual Robert Krane Lecture - Basic Science Most Likely to Translate into Clinical Medicine in the Next 5 Years: When Can I Print a Penis
4th Annual Robert Krane Lecture - Basic Science Most Likely to Translate into Clinical Medicine in the Next 5 Years: When Can I Print a Penis
Johanna Hannan, PhD
11:10 a.m. - 11:20 a.m.
#006: Topical Abdominal Application of Curcumin-containing Nanoparticles Protects Erectile Function and Correlates with Corporal Expression of Inflammatory Markers (HO-1 and Nf- kB) in a Rat Model of Type-2-diabetes
#006: Topical Abdominal Application of Curcumin-containing Nanoparticles Protects Erectile Function and Correlates with Corporal Expression of Inflammatory Markers (HO-1 and Nf- kB) in a Rat Model of Type-2-diabetes
A. Draganski
11:20 a.m. - 11:30 a.m.
#007: The Effects of Local Delivery of Lipoic Acid and 4-Hydroxy-2,5,6-triaminopyrimidine Sulfate after Bilateral Nerve Crush Injury in the Rat Animal Model
#007: The Effects of Local Delivery of Lipoic Acid and 4-Hydroxy-2,5,6-triaminopyrimidine Sulfate after Bilateral Nerve Crush Injury in the Rat Animal Model
N.M. Haney
11:30 a.m. - 11:40 a.m.
#008: Ivabradine (I(f) Funny Channel Current Blocker, Corlanor®) Inhibits Human Corpus Cavernosum Contraction in Vitro via Interference with the Calcium and Potassium Transfer: A Potential Option for Erectile Dysfunction
#008: Ivabradine (I(f) Funny Channel Current Blocker, Corlanor®) Inhibits Human Corpus Cavernosum Contraction in Vitro via Interference with the Calcium and Potassium Transfer: A Potential Option for Erectile Dysfunction
L. Alzweri
11:40 a.m. - 12:00 p.m.
Low-Intensity Shock Wave Therapy: Current Evidence and Future Outlook
Low-Intensity Shock Wave Therapy: Current Evidence and Future Outlook
Ranjith Ramasamy, MD
10:30 a.m. - 12:00 p.m.
Female Sexual Function, Part I – Diagnosis and Non-medical ManagementLocation: Salon A+BModerators: Irwin Goldstein, MD & Tami Rowen, MD, MS, FACOG
10:30 a.m. - 10:45 a.m.
Updates in Female Sexual Function – Most Noteworthy Literature from 2016-2017 on Diagnosis and Non-medical Management
Updates in Female Sexual Function – Most Noteworthy Literature from 2016-2017 on Diagnosis and Non-medical Management
Sharon Parish, MD, NCMP
10:45 a.m. - 10:55 a.m.
#009: Histological Characterization of Periurethral Tissue: Potential Role in Sexual Function
#009: Histological Characterization of Periurethral Tissue: Potential Role in Sexual Function
D. Gaudet
10:45 a.m. - 10:55 a.m.
#010: Simulation of Mid-Urethral Incontinence Sling Surgery Using Cadavers: Impact on Innervation and Glandular Tissue
#010: Simulation of Mid-Urethral Incontinence Sling Surgery Using Cadavers: Impact on Innervation and Glandular Tissue
D. Gaudet
10:55 a.m. - 11:05 a.m.
#011: Successful Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/PBS) in Women with Provoked Vestibulodynia (PVD)
#011: Successful Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/PBS) in Women with Provoked Vestibulodynia (PVD)
Rachel Rubin, MD
11:05 a.m. - 11:25 a.m.
ISSM Lecture – First Things First: The Importance of Obtaining a Correct Diagnosis – How Important is It?
ISSM Lecture – First Things First: The Importance of Obtaining a Correct Diagnosis – How Important is It?
Annamaria Giraldi, MD, PhD
11:25 a.m. - 11:37 a.m.
Debate - Psychosexual Counseling is Mandatory in Treating HSDD - Pro
Debate - Psychosexual Counseling is Mandatory in Treating HSDD - Pro
Jordan Rullo, PhD, LP
11:37 a.m. - 11:49 a.m.
Debate - Psychosexual Counseling is Mandatory in Treating HSDD - Con
Debate - Psychosexual Counseling is Mandatory in Treating HSDD - Con
Stanley Althof, PhD
11:49 a.m. - 12:00 p.m.
Debate - Psychosexual Counseling is Mandatory in Treating HSDD - Discussion
Debate - Psychosexual Counseling is Mandatory in Treating HSDD - Discussion
11:30 a.m. - 12:00 p.m.
Pornography and Sexual FunctionLocation: Salon EModerator: Hartmut Porst, MD
11:30 a.m. - 12:00 p.m.
Pornography: Data on Use & Misuse: Clinical Tools & Implications
Pornography: Data on Use & Misuse: Clinical Tools & Implications
Marty Klein, PhD
Afternoon
12:00 p.m. - 01:30 p.m.
Industry Sponsored Lunch SymposiumLocation: Salon F
show program01:30 p.m. - 03:00 p.m.
Other Male Sexual DysfunctionLocation: Salon EModerators: Lawrence Hakim, MD, FACS & Zhong-Cheng Xin, MD, PhD
01:30 p.m. - 01:45 p.m.
Updates in Libido, Orgasm, Ejaculation, and Other Sexual Dysfunctions – Most Noteworthy Literature from 2016-2017
Updates in Libido, Orgasm, Ejaculation, and Other Sexual Dysfunctions – Most Noteworthy Literature from 2016-2017
Alexander Pastuszak, MD, PhD
01:45 p.m. - 01:55 p.m.
#012: Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis
#012: Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis
A. Potts Bleakman
01:55 p.m. - 02:05 p.m.
#013: Description of a Patient Reported Outcome approved by FDA for use in Phase III studies in Premature Ejaculation
#013: Description of a Patient Reported Outcome approved by FDA for use in Phase III studies in Premature Ejaculation
M.G. Wyllie
02:05 p.m. - 02:25 p.m.
Management Strategies for Inhibited Orgasm
Management Strategies for Inhibited Orgasm
Alan Shindel, MD
02:25 p.m. - 02:40 p.m.
Pain, Pain, Pain – What to do with Idiopathic Penile and Ejaculatory Pain
Pain, Pain, Pain – What to do with Idiopathic Penile and Ejaculatory Pain
John Mulhall, MD
02:40 p.m. - 03:00 p.m.
Updates on Premature Ejaculation – Have we Made any Progress in Last 3 Years?
Updates on Premature Ejaculation – Have we Made any Progress in Last 3 Years?
Alan Shindel, MD
01:30 p.m. - 03:30 p.m.
Female Sexual Function, Part II – Medical ManagementLocation: Salon A+BModerators: Sue Goldstein, CCRC, CSE, IF & Leah Millheiser, MD
01:30 p.m. - 01:45 p.m.
Updates in Female Sexual Function – Most Noteworthy Literature from 2016-2017 on Medical Therapies
Updates in Female Sexual Function – Most Noteworthy Literature from 2016-2017 on Medical Therapies
Rachel Rubin, MD
01:45 p.m. - 01:55 p.m.
#014: The Investigational Drug Bremelanotide for Hypoactive Sexual Desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies
#014: The Investigational Drug Bremelanotide for Hypoactive Sexual Desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies
A.H. Clayton
01:55 p.m. - 02:05 p.m.
#015: Efficacy of Flibanserin by Duration of Hypoactive Sexual Desire Disorder in Premenopausal Women
#015: Efficacy of Flibanserin by Duration of Hypoactive Sexual Desire Disorder in Premenopausal Women
Irwin Goldstein, MD
02:05 p.m. - 02:20 p.m.
Practical Algorithms for Medical Therapies in Contemporary Practice - Estrogens and Progestogens
Practical Algorithms for Medical Therapies in Contemporary Practice - Estrogens and Progestogens
Irwin Goldstein, MD
02:20 p.m. - 02:35 p.m.
Practical Algorithms for Medical Therapies in Contemporary Practice - Androgens
Practical Algorithms for Medical Therapies in Contemporary Practice - Androgens
Tami Rowen, MD, MS, FACOG
02:35 p.m. - 02:50 p.m.
Practical Algorithms for Medical Therapies in Contemporary Practice - Non-hormonal Agents
Practical Algorithms for Medical Therapies in Contemporary Practice - Non-hormonal Agents
James Simon, MD, CCD, NCMP, FACOG
02:50 p.m. - 03:05 p.m.
Flibanserin and Alcohol: Significant Interaction or Much Ado About Nothing
Flibanserin and Alcohol: Significant Interaction or Much Ado About Nothing
Leah Millheiser, MD
03:05 p.m. - 03:30 p.m.
Moderated, Case-based Panel Discussion on Difficult to Treat Scenarios
Moderated, Case-based Panel Discussion on Difficult to Treat Scenarios
Irwin Goldstein, MD (moderator), Seth Cohen, MD, MPH, Annamaria Giraldi, MD, PhD & Tami Rowen, MD, MS, FACOG
01:30 p.m. - 03:30 p.m.
Podium/Moderated Poster Session: Basic ScienceLocation: Salon C+DModerators: Trinity Bivalacqua, MD, PhD & Kathleen Hwang, MD
01:30 p.m. - 01:37 p.m.
#016: Fidgetin-like 2, a Novel Microtubule Regulator, can be Targeted to Promote Nerve Regeneration and Improve Erectile Function after Cavernous Nerve Injury
#016: Fidgetin-like 2, a Novel Microtubule Regulator, can be Targeted to Promote Nerve Regeneration and Improve Erectile Function after Cavernous Nerve Injury
L. Baker
01:37 p.m. - 01:44 p.m.
#017: Differential Effects on MPG Neurons and Penile Vasculature after Conformal Prostate Radiation in Rats
#017: Differential Effects on MPG Neurons and Penile Vasculature after Conformal Prostate Radiation in Rats
M.R. Odom
01:44 p.m. - 01:51 p.m.
#018: TNF-alpha Inhibition Improves Parasympathetic Nerve Function and is Associated with Altered Macrophage Infiltration of the Major Pelvic Ganglion following Nerve Injury
#018: TNF-alpha Inhibition Improves Parasympathetic Nerve Function and is Associated with Altered Macrophage Infiltration of the Major Pelvic Ganglion following Nerve Injury
Nikolai Sopko, MD, PhD
01:51 p.m. - 01:58 p.m.
#019: Sonic Hedgehog Promotes Cavernous Nerve Regeneration by Inducing Cavernous Nerve Sprouting and Sprouting Potential is Reduced with Age
#019: Sonic Hedgehog Promotes Cavernous Nerve Regeneration by Inducing Cavernous Nerve Sprouting and Sprouting Potential is Reduced with Age
Carol Podlasek, PhD
01:58 p.m. - 02:05 p.m.
#020: Erectile Dysfunction Genomics (EDGE): A GWAS of Erectile Dysfunction in the Kaiser Permanente of Northern California (KPNC) Genetic Epidemiology Research on Aging (GERA) Cohort
#020: Erectile Dysfunction Genomics (EDGE): A GWAS of Erectile Dysfunction in the Kaiser Permanente of Northern California (KPNC) Genetic Epidemiology Research on Aging (GERA) Cohort
M.R. Palmer
02:05 p.m. - 02:12 p.m.
#021: Topically Applied Sildenafil-nanoparticles Improve Erectile Function in an Aging-rat Model of Erectile Dysfunction
#021: Topically Applied Sildenafil-nanoparticles Improve Erectile Function in an Aging-rat Model of Erectile Dysfunction
M. Tar
02:12 p.m. - 02:17 p.m.
#160: Defocused Low-energy Shock Wave can Stimulate Penile Tissues to Produce more Energy for Growth and Proliferation in a DMED Rat Model
#160: Defocused Low-energy Shock Wave can Stimulate Penile Tissues to Produce more Energy for Growth and Proliferation in a DMED Rat Model
Hyun Cheol Jeong, MD
02:17 p.m. - 02:22 p.m.
#161: Low Intensity Extracorporeal Shock Wave Therapy Activates Endogenous Progenitor/Stem Cells as Indicated by Histone 3 Phosphorylation
#161: Low Intensity Extracorporeal Shock Wave Therapy Activates Endogenous Progenitor/Stem Cells as Indicated by Histone 3 Phosphorylation
A.B. Reed-Maldonado
02:22 p.m. - 02:27 p.m.
#162: Dysregulated NO Signaling in the Lower Genitourinary Tract: A Common Mechanism of Erection and Micturition Dysfunction in a Mouse Model of Sickle Cell Disease
#162: Dysregulated NO Signaling in the Lower Genitourinary Tract: A Common Mechanism of Erection and Micturition Dysfunction in a Mouse Model of Sickle Cell Disease
Arthur Burnett, MD
02:27 p.m. - 02:32 p.m.
#163: Effect of the Cranberry (Vaccinium Macrocarpon) Extract on the Relaxation of Human Corpus Cavernosum Tissue in Vitro: Can Cranberries Contribute to Reduce the Incidence of Erectile Dysfunction?
#163: Effect of the Cranberry (Vaccinium Macrocarpon) Extract on the Relaxation of Human Corpus Cavernosum Tissue in Vitro: Can Cranberries Contribute to Reduce the Incidence of Erectile Dysfunction?
L. Alzweri
02:32 p.m. - 02:37 p.m.
#164: The Effects of Multiple Adipose-Derived Stem Cell Intracorporeal Injections on Erectile Dysfunction in a Rat Model of Cavernosal Nerve Injury
#164: The Effects of Multiple Adipose-Derived Stem Cell Intracorporeal Injections on Erectile Dysfunction in a Rat Model of Cavernosal Nerve Injury
N.M. Haney
02:37 p.m. - 02:42 p.m.
#165: Optimization of Sonic Hedgehog Delivery from Self-assembled Nanofiber Hydrogels to prevent ED
#165: Optimization of Sonic Hedgehog Delivery from Self-assembled Nanofiber Hydrogels to prevent ED
Carol Podlasek, PhD
02:42 p.m. - 02:47 p.m.
#166: Novel Noninvasive Quantification of 2-D ShearWaveTM Elastography(SWE) for Corpus Cavernosum lesions in Hyperlipidemia Induced Erectile Dysfunction Rabbits
#166: Novel Noninvasive Quantification of 2-D ShearWaveTM Elastography(SWE) for Corpus Cavernosum lesions in Hyperlipidemia Induced Erectile Dysfunction Rabbits
J. Hu
02:47 p.m. - 02:52 p.m.
#167: Low Testosterone as a Driver of Prostate Inflammation in Hypogonadal Men
#167: Low Testosterone as a Driver of Prostate Inflammation in Hypogonadal Men
A.T. Gabrielson
02:52 p.m. - 02:57 p.m.
#168: Subcutaneous Leydig Stem Cell Autograft in Mice: An Approach to Increase Serum Testosterone
#168: Subcutaneous Leydig Stem Cell Autograft in Mice: An Approach to Increase Serum Testosterone
H. Arora
02:57 p.m. - 03:02 p.m.
#169: Antioxidant and Antifibrotic Effect of a Herbal Formulation in vitro and in the Experimental Andropause via Nrf2/HO-1 Signalling Pathway
#169: Antioxidant and Antifibrotic Effect of a Herbal Formulation in vitro and in the Experimental Andropause via Nrf2/HO-1 Signalling Pathway
Hyun Cheol Jeong, MD
03:02 p.m. - 03:07 p.m.
#170: Short-term Exposure to High Glucose Alters Acetylcholine Sensitivity and Maximal Relaxation in Male and Female Rat Pudendal Artery, Respectively, Which is Reversed With Testosterone Incubation
#170: Short-term Exposure to High Glucose Alters Acetylcholine Sensitivity and Maximal Relaxation in Male and Female Rat Pudendal Artery, Respectively, Which is Reversed With Testosterone Incubation
N.S. Klee
03:07 p.m. - 03:12 p.m.
#171: Effects of Combination of Korean Red Ginseng Extract and Hydrogen-rich Water on Spermatogenesis and Sperm Motility in the Mouse Model
#171: Effects of Combination of Korean Red Ginseng Extract and Hydrogen-rich Water on Spermatogenesis and Sperm Motility in the Mouse Model
Nam Cheol Park, MD, PhD
03:12 p.m. - 03:17 p.m.
#172: Cavernous Nerve Crush Injury Increases Apoptosis in a Time Dependent Manner in the Entire Pelvic Plexus
#172: Cavernous Nerve Crush Injury Increases Apoptosis in a Time Dependent Manner in the Entire Pelvic Plexus
Carol Podlasek, PhD
03:17 p.m. - 03:22 p.m.
#173: Sonic Hedgehog Regulation of Human Rhabdosphincter Muscle
#173: Sonic Hedgehog Regulation of Human Rhabdosphincter Muscle
Carol Podlasek, PhD
03:30 p.m. - 04:00 p.m.
Coffee BreakLocation: Salon H+I
04:00 p.m. - 05:30 p.m.
Moderated Poster Session: Other / PriapismLocation: Salon A+BModerators: John Mulhall, MD & Alexander Pastuszak, MD, PhD
04:00 p.m. - 04:05 p.m.
#174: Financial Conflicts of Interest: A Link between Funding and Outcomes in Sexual Medicine
#174: Financial Conflicts of Interest: A Link between Funding and Outcomes in Sexual Medicine
N. Farber
04:05 p.m. - 04:10 p.m.
#175: Reinventing the Selfie: Telemedicine in a Tertiary Referral Sexual Medicine Practice
#175: Reinventing the Selfie: Telemedicine in a Tertiary Referral Sexual Medicine Practice
V. Trofimenko
04:10 p.m. - 04:15 p.m.
#176: A Study Protocol for a Critical Appraisal of The Sexual Health Rehabilitation Action Plan (SHRAP)
#176: A Study Protocol for a Critical Appraisal of The Sexual Health Rehabilitation Action Plan (SHRAP)
C. Zarowski
04:15 p.m. - 04:20 p.m.
#177: Vasectomy Practice Patterns Among Non-Urologists and Compliance with the AUA 2012 Vasectomy Guidelines
#177: Vasectomy Practice Patterns Among Non-Urologists and Compliance with the AUA 2012 Vasectomy Guidelines
N. Posielski
04:20 p.m. - 04:25 p.m.
#178: Low Adherence to Post-Vasectomy Semen Analysis in the VA Population
#178: Low Adherence to Post-Vasectomy Semen Analysis in the VA Population
R. Owusu
04:25 p.m. - 04:30 p.m.
#179: Preoperative Group Education and Preparedness for Prostatectomy Among Men with Prostate Cancer
#179: Preoperative Group Education and Preparedness for Prostatectomy Among Men with Prostate Cancer
K. Dunlap
04:30 p.m. - 04:35 p.m.
#180: Increased Orgasmic Intensity After Radical Prostatectomy: Prevalence And Predictors
#180: Increased Orgasmic Intensity After Radical Prostatectomy: Prevalence And Predictors
H. Levey Bernie
04:35 p.m. - 04:40 p.m.
#181: A 10-year Interval Web-based Survey for Premature Ejaculation: The Korean Internet Sexuality Survey (KISS) 2016
#181: A 10-year Interval Web-based Survey for Premature Ejaculation: The Korean Internet Sexuality Survey (KISS) 2016
H. Son
04:45 p.m. - 04:50 p.m.
#183: Metabolic Syndrome is an Independent Risk Factor for Acquired Premature Ejaculation
#183: Metabolic Syndrome is an Independent Risk Factor for Acquired Premature Ejaculation
S.U. Jeh
04:50 p.m. - 04:55 p.m.
#184: On-demand use of Tramadol, Sildenafil, Paroxetine and Local Anaesthetics for the Management of Premature Ejaculation: A Randomized Placebo-controlled Clinical Trial
#184: On-demand use of Tramadol, Sildenafil, Paroxetine and Local Anaesthetics for the Management of Premature Ejaculation: A Randomized Placebo-controlled Clinical Trial
M. Abou Farha
04:55 p.m. - 05:00 p.m.
#185: Use of 3T Functional MRI in Evaluation of Eugonadal Men with Normal Erections But Persistent Delayed Ejaculation or Anejaculation: A Pilot Study
#185: Use of 3T Functional MRI in Evaluation of Eugonadal Men with Normal Erections But Persistent Delayed Ejaculation or Anejaculation: A Pilot Study
R. Flannigan
05:00 p.m. - 05:05 p.m.
#186: The Effect of Buspirone on Refractory Neurogenic Retrograde Ejaculation to Pseudoephedrine
#186: The Effect of Buspirone on Refractory Neurogenic Retrograde Ejaculation to Pseudoephedrine
S.T. Ahn
05:05 p.m. - 05:10 p.m.
#187: Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
#187: Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
K. Karna
05:10 p.m. - 05:15 p.m.
#188: Lumbar and Sacral Spinal-Mediated Neurogenic Sexual Dysfunction: Pathophysiology, Diagnosis and Treatment
#188: Lumbar and Sacral Spinal-Mediated Neurogenic Sexual Dysfunction: Pathophysiology, Diagnosis and Treatment
Sue Goldstein, CCRC, CSE, IF
05:15 p.m. - 05:20 p.m.
#190: Low Hanging Fruit: A Simple Surgical Intervention for Chronic Orchialgia Secondary to a Low Hanging Testicle after Varicocelectomy
#190: Low Hanging Fruit: A Simple Surgical Intervention for Chronic Orchialgia Secondary to a Low Hanging Testicle after Varicocelectomy
M. Mendez
05:20 p.m. - 05:25 p.m.
#191: Adult Acquired Buried Penis: Experience and Outcomes after Surgical Correction at a Single Institution
#191: Adult Acquired Buried Penis: Experience and Outcomes after Surgical Correction at a Single Institution
J. Piotrowski
04:00 p.m. - 05:30 p.m.
Moderated Poster Session: BPH / Reconstruction / IncontinenceLocation: Salon C+DModerators: Tobias Kohler, MD, MPH & Richard Santucci, MD
04:00 p.m. - 04:07 p.m.
#192: Five Year Sexual Function Results of the Multi-Center, Prospective, Randomized Study of the Prostatic Urethral Lift (PUL)
#192: Five Year Sexual Function Results of the Multi-Center, Prospective, Randomized Study of the Prostatic Urethral Lift (PUL)
R. Valenzuela
04:07 p.m. - 04:14 p.m.
#193: Comparison of Lower Urinary Tract Symptoms and Sexual Function Response to Convective Radiofrequency Thermal Therapy of Prostate (Rezűm®) to MTOPS Study Cohort
#193: Comparison of Lower Urinary Tract Symptoms and Sexual Function Response to Convective Radiofrequency Thermal Therapy of Prostate (Rezűm®) to MTOPS Study Cohort
B. Holland
04:14 p.m. - 04:21 p.m.
#194: The WATER Study Sexual Function Results – A Phase III Blinded Randomized Parallel Group Trial of Aquablation vs. Transurethral Resection of the Prostate with Blinded Outcome Assessment for Moderate-to-Severe LUTS in men with Benign Prostatic Hyperplasia
#194: The WATER Study Sexual Function Results – A Phase III Blinded Randomized Parallel Group Trial of Aquablation vs. Transurethral Resection of the Prostate with Blinded Outcome Assessment for Moderate-to-Severe LUTS in men with Benign Prostatic Hyperplasia
C. Tallman
04:21 p.m. - 04:28 p.m.
#195: Intraprostatic Injection of Botulinum Toxin-A in Patients with Refractory Chronic Pelvic Pain Syndrome: The Transurethral vs. Transrectal Approach
#195: Intraprostatic Injection of Botulinum Toxin-A in Patients with Refractory Chronic Pelvic Pain Syndrome: The Transurethral vs. Transrectal Approach
M. Abou Farha
04:28 p.m. - 04:35 p.m.
#196: Refining Male Sling Selectivity Improves Outcomes: Role of Standing Cough Test in Physical Demonstration of Mild Male Stress Urinary Incontinence
#196: Refining Male Sling Selectivity Improves Outcomes: Role of Standing Cough Test in Physical Demonstration of Mild Male Stress Urinary Incontinence
B.R. Viers
04:35 p.m. - 04:42 p.m.
#197: Artificial Urinary Sphincter Revision for Recurrent Incontinence: Single Component Replacement is Both Feasible and Efficacious
#197: Artificial Urinary Sphincter Revision for Recurrent Incontinence: Single Component Replacement is Both Feasible and Efficacious
G. Joice
04:42 p.m. - 04:49 p.m.
#198: Comparison of Adjuvant Radiation Therapy Before or After Artificial Urinary Sphincter Placement: A Multi-Institutional Analysis
#198: Comparison of Adjuvant Radiation Therapy Before or After Artificial Urinary Sphincter Placement: A Multi-Institutional Analysis
N.M. Haney
04:49 p.m. - 04:56 p.m.
#199: Is Removal of the Pressure Regulating Balloon Necessary after Artificial Urinary Sphincter Cuff Erosion?
#199: Is Removal of the Pressure Regulating Balloon Necessary after Artificial Urinary Sphincter Cuff Erosion?
M.J. McKibben
04:56 p.m. - 05:03 p.m.
#200: "Stiction Syndrome": Non-Operative Management of Patients with Difficult AMS 700-Series Inflation
#200: "Stiction Syndrome": Non-Operative Management of Patients with Difficult AMS 700-Series Inflation
B.R. Viers
05:03 p.m. - 05:10 p.m.
#201: Survey on the Contemporary Management of Intraoperative Urethral Injuries during Penile Prosthesis Implantation
#201: Survey on the Contemporary Management of Intraoperative Urethral Injuries during Penile Prosthesis Implantation
S.J. Sexton
05:10 p.m. - 05:17 p.m.
#202: Excision and Primary Anastomosis Reconstruction for Traumatic Strictures of The Penile Urethra
#202: Excision and Primary Anastomosis Reconstruction for Traumatic Strictures of The Penile Urethra
B.R. Viers
05:17 p.m. - 05:24 p.m.
#203: Patients’ Perspectives on the Impact of Moderate-to-Severe Genital Psoriasis
#203: Patients’ Perspectives on the Impact of Moderate-to-Severe Genital Psoriasis
A. Potts Bleakman
05:17 p.m. - 05:24 p.m.
#204: The Burden of Moderate-to-Severe Genital Psoriasis: Patients’ Perspective on Symptoms
#204: The Burden of Moderate-to-Severe Genital Psoriasis: Patients’ Perspective on Symptoms
A. Potts Bleakman
04:00 p.m. - 05:30 p.m.
Moderated Poster Session: Erectile DysfunctionLocation: Salon EModerators: Trinity Bivalacqua, MD, PhD , Arthur Burnett, MD & Jason Greenfield, MD
04:00 p.m. - 04:05 p.m.
#205: The Effect of Insulin-like Growth Factor-1 (IGF-1) Delivered via Polymeric PLGA Microspheres on Erectile Function after Bilateral Cavernous Nerve Injury in the Rat
#205: The Effect of Insulin-like Growth Factor-1 (IGF-1) Delivered via Polymeric PLGA Microspheres on Erectile Function after Bilateral Cavernous Nerve Injury in the Rat
N.M. Haney
04:05 p.m. - 04:10 p.m.
#206: Association between Habitual Cannabis use in Young Men and IIEF Sexual Domain Scores
#206: Association between Habitual Cannabis use in Young Men and IIEF Sexual Domain Scores
A. Suarez-Sarmiento
04:10 p.m. - 04:15 p.m.
#207: Single Center Experience Using Doppler Assessment for Erectile Dysfunction (ED) Complaint in More Than 500 Patients
#207: Single Center Experience Using Doppler Assessment for Erectile Dysfunction (ED) Complaint in More Than 500 Patients
E. Schommer
04:15 p.m. - 04:20 p.m.
#208: Low-Intensity Shock Wave Therapy for Treatment of Vasculogenic Erectile Dysfunction: Phase 1 Results of the Dornier Aries in the First United States Clinical Trial
#208: Low-Intensity Shock Wave Therapy for Treatment of Vasculogenic Erectile Dysfunction: Phase 1 Results of the Dornier Aries in the First United States Clinical Trial
Irwin Goldstein, MD
04:20 p.m. - 04:25 p.m.
#209: Self- Administered Intraspongiosal (IS) Injection Therapy for the Management of Cold Glans Syndrome
#209: Self- Administered Intraspongiosal (IS) Injection Therapy for the Management of Cold Glans Syndrome
A. Winter
04:25 p.m. - 04:30 p.m.
#210: The Safety and Outcomes of Penile Implant Surgery in the Elderly Population
#210: The Safety and Outcomes of Penile Implant Surgery in the Elderly Population
John Mulhall, MD
04:30 p.m. - 04:35 p.m.
#211: Prosthetic Sparing Surgery: Risk Factors for Infection and Keys to Success
#211: Prosthetic Sparing Surgery: Risk Factors for Infection and Keys to Success
J.A. Beilan
04:35 p.m. - 04:40 p.m.
#212: The Relationship Between Infection Severity, Microorganisms, and Surgical Intervention in Inflatable Penile Prosthesis Infections
#212: The Relationship Between Infection Severity, Microorganisms, and Surgical Intervention in Inflatable Penile Prosthesis Infections
Martin Gross, MD
04:35 p.m. - 04:40 p.m.
#213: New Findings Regarding the Timeline of Microorganisms in Inflatable Penile Prosthesis Infections
#213: New Findings Regarding the Timeline of Microorganisms in Inflatable Penile Prosthesis Infections
Martin Gross, MD
04:40 p.m. - 04:45 p.m.
#214: Infection Retardant Coatings Impact On Bacterial Presence In Penile Prosthesis Surgery: A Multicenter Study
#214: Infection Retardant Coatings Impact On Bacterial Presence In Penile Prosthesis Surgery: A Multicenter Study
K. Jani
04:45 p.m. - 04:50 p.m.
#215: Implant Selection Patterns and Reoperation Rates Amongst HIV Positive and Negative Patients that Underwent Penile Prosthesis Surgery
#215: Implant Selection Patterns and Reoperation Rates Amongst HIV Positive and Negative Patients that Underwent Penile Prosthesis Surgery
D. Asafu-Adjei
04:50 p.m. - 04:55 p.m.
#216: The Impact of Immediate Salvage Surgery and Time until Re-implantation on Corporal Length in Patients Presenting with Penile Implant Infections
#216: The Impact of Immediate Salvage Surgery and Time until Re-implantation on Corporal Length in Patients Presenting with Penile Implant Infections
D.M. Lopategui
04:55 p.m. - 05:00 p.m.
#217: Maximization of Penile Length and Girth with Inflatable Penile Prosthesis Insertion: A Cadaver Study
#217: Maximization of Penile Length and Girth with Inflatable Penile Prosthesis Insertion: A Cadaver Study
M.J. Rogers
05:00 p.m. - 05:05 p.m.
#218: Rear Tip Extenders During Inflatable Penile Prosthesis Placement: Impact on need for revision
#218: Rear Tip Extenders During Inflatable Penile Prosthesis Placement: Impact on need for revision
L. Alzweri
05:05 p.m. - 05:10 p.m.
#219: Curvature Correction Techniques For Residual Curvature After Penile Prosthesis Placement: From Personal Opinion To Objective Data
#219: Curvature Correction Techniques For Residual Curvature After Penile Prosthesis Placement: From Personal Opinion To Objective Data
Gerard Henry, MD
05:10 p.m. - 05:15 p.m.
#220: IPP Surgery under Local Anesthesia, Multistep Approach
#220: IPP Surgery under Local Anesthesia, Multistep Approach
S.H. Park
05:15 p.m. - 05:20 p.m.
#221: An In-vivo a Bio-mechanical Comparison Between Inflatable Penile Prosthesis
#221: An In-vivo a Bio-mechanical Comparison Between Inflatable Penile Prosthesis
T.S. Hakky
05:20 p.m. - 05:25 p.m.
#222: Beyond the Bench: Surgical Technique Development for Implantation of a Novel Penile Prosthesis in Human Corpora Cavernosa
#222: Beyond the Bench: Surgical Technique Development for Implantation of a Novel Penile Prosthesis in Human Corpora Cavernosa
Brian Le, MD
05:25 p.m. - 05:30 p.m.
#223: Use of 3D printing to Prototype a Custom Shape Memory Alloy Penile Prosthesis
#223: Use of 3D printing to Prototype a Custom Shape Memory Alloy Penile Prosthesis
Brian Le, MD
05:30 p.m. - 06:00 p.m.
SMSNA Business Meeting (members only)Location: Salon E
Saturday, October 28, 2017
Morning
07:00 a.m. - 08:00 a.m.
SMSNA Special Breakfast SymposiumLocation: Salon F
show program08:00 a.m. - 10:00 a.m.
MedicalLocation: Salon EModerators: Mohit Khera, MD & Run Wang, MD, FACS
08:00 a.m. - 08:20 a.m.
“The prosthesis works great… but it didn’t fix my nocturia” - Improving Communication Skills in a Sexual Medicine Practice
“The prosthesis works great… but it didn’t fix my nocturia” - Improving Communication Skills in a Sexual Medicine Practice
Bruce Kava, MD
08:20 a.m. - 08:30 a.m.
Serendipity: The True Story of How Sildenafil Was Discovered
Serendipity: The True Story of How Sildenafil Was Discovered
Irwin Goldstein, MD
08:30 a.m. - 08:40 a.m.
Evidence for and against – Lifestyle Management Should be First Line Therapy for ED - Evidence For
Evidence for and against – Lifestyle Management Should be First Line Therapy for ED - Evidence For
Gregory Broderick, MD
08:40 a.m. - 08:50 a.m.
Evidence for and against – Lifestyle Management Should be First Line Therapy for ED - Evidence Against
Evidence for and against – Lifestyle Management Should be First Line Therapy for ED - Evidence Against
Gerald Brock, MD
08:50 a.m. - 09:10 a.m.
How and Why CV Screening Should be Implemented into a Sexual Medicine Practice
How and Why CV Screening Should be Implemented into a Sexual Medicine Practice
Stephen Kopecky, MD
09:10 a.m. - 09:20 a.m.
Snake Oil or Next Big Thing? -Platelet-rich Plasma
Snake Oil or Next Big Thing? -Platelet-rich Plasma
Gregory Broderick, MD
09:20 a.m. - 09:30 a.m.
Snake Oil or Next Big Thing? -Stem Cells
Snake Oil or Next Big Thing? -Stem Cells
Irwin Goldstein, MD
09:30 a.m. - 09:40 a.m.
Snake Oil or Next Big Thing?- Fat Transfer
Snake Oil or Next Big Thing?- Fat Transfer
Nelson Bennett, Jr, MD
09:40 a.m. - 09:45 a.m.
Snake Oil or Next Big Thing? - - Regulator Environment Comment
Snake Oil or Next Big Thing? - - Regulator Environment Comment
Trinity Bivalacqua, MD, PhD
09:45 a.m. - 10:00 a.m.
Panelist Discussion and Audience Questions
Panelist Discussion and Audience Questions
John Mulhall, MD (moderator), Nelson Bennett, Jr, MD, Trinity Bivalacqua, MD, PhD , Gregory Broderick, MD, Lawrence Hakim, MD, FACS, Tom Lue, MD & Run Wang, MD, FACS
10:00 a.m. - 10:30 a.m.
Coffee BreakLocation: Salon H+I
10:30 a.m. - 12:00 p.m.
Men’s Health Symposium, Part I - HypogonadismLocation: Salon EModerators: Jason Jameson, MD & Kenneth Mitchell, MPAS, PA-C
10:30 a.m. - 10:50 a.m.
Workup / Treatment
Workup / Treatment
Kelly Chiles, MD
10:50 a.m. - 11:10 a.m.
Risks / Benefits Review (except cardiovascular / prostate cancer)
Risks / Benefits Review (except cardiovascular / prostate cancer)
Bruce Redmon, MD
11:10 a.m. - 11:30 a.m.
Review of Controversies: Cardiovascular and Prostate Cancer
Review of Controversies: Cardiovascular and Prostate Cancer
Mohit Khera, MD
11:30 a.m. - 11:45 a.m.
Anti-Aging Controversies
Anti-Aging Controversies
Martin Miner, MD
11:45 a.m. - 12:00 p.m.
Q&A
Q&A
10:30 a.m. - 12:00 p.m.
Erectile Dysfunction SurgeryLocation: Salon C+DModerators: Justin Parker, MD, LeRoy Jones, Jr., MD & Nikolai Sopko, MD, PhD
10:30 a.m. - 10:45 a.m.
Updates in ED Surgery – Most Noteworthy Literature from 2016-2017
Updates in ED Surgery – Most Noteworthy Literature from 2016-2017
Brian Le, MD
10:45 a.m. - 11:00 a.m.
Best Practice: Penile Prosthesis Infection Prevention
Best Practice: Penile Prosthesis Infection Prevention
Hossein Sadeghi-Nejad, MD, FACS
11:00 a.m. - 11:10 a.m.
#022: Emerging Mechanic Failure and Complications Related to Ectopic Placement of Reservoir
#022: Emerging Mechanic Failure and Complications Related to Ectopic Placement of Reservoir
J. Clavell Hernandez
11:10 a.m. - 11:20 a.m.
#023: Moving Beyond Hydraulics: Safety and Efficacy of Magnetic Induction for a New Penile Prosthesis in Human Cadavers and Animal Tissue
#023: Moving Beyond Hydraulics: Safety and Efficacy of Magnetic Induction for a New Penile Prosthesis in Human Cadavers and Animal Tissue
Brian Le, MD
11:20 a.m. - 11:30 a.m.
#024: “Andrianne Mini-jupette” Graft at the Time of Inflatable Penile Prosthesis Placement for the Management of Post-prostatectomy Climacturia and Minimal Urinary Incontinence
#024: “Andrianne Mini-jupette” Graft at the Time of Inflatable Penile Prosthesis Placement for the Management of Post-prostatectomy Climacturia and Minimal Urinary Incontinence
Faysal Yafi, MD, FRCSC
11:30 a.m. - 12:00 p.m.
Practical Advice on Achieving Optimal Outcomes
Practical Advice on Achieving Optimal Outcomes
Steven Wilson, MD (moderator), Rafael Carrion, MD, Culley Carson III, MD, Brian Christine, MD, Edward Karpman, MD & Tobias Kohler, MD, MPH
10:30 a.m. - 12:00 p.m.
LGBT Medicine and SurgeryLocation: Salon A+BModerators: Tung-Chin (Mike) Hsieh, MD & Ira Sharlip, MD
10:30 a.m. - 10:45 a.m.
Updates in LGBT Medicine and Surgery – Most Noteworthy Literature from 2016-2017
Updates in LGBT Medicine and Surgery – Most Noteworthy Literature from 2016-2017
Helen L. Bernie, DO, MPH
10:45 a.m. - 11:05 a.m.
Surgical Demonstration (video) of Reassignment Surgery
Surgical Demonstration (video) of Reassignment Surgery
Richard Santucci, MD
11:15 a.m. - 11:25 a.m.
#026: Neophallus Penile Prosthesis Placement: Anatomic and Post-Surgical Challenges, Device Selection Criteria, and Proposed Surgical Technique
#026: Neophallus Penile Prosthesis Placement: Anatomic and Post-Surgical Challenges, Device Selection Criteria, and Proposed Surgical Technique
M. Garcia
11:25 a.m. - 11:35 a.m.
#027: Robotic-Assisted Vaginectomy, Mobilization of Vaginal Mucosa for Urethral Lengthening and a Gracilis Muscle Flap for Phalloplasty: A Novel Technique for Female-to-Male Genital Reconstruction
#027: Robotic-Assisted Vaginectomy, Mobilization of Vaginal Mucosa for Urethral Lengthening and a Gracilis Muscle Flap for Phalloplasty: A Novel Technique for Female-to-Male Genital Reconstruction
L. Zhao
11:35 a.m. - 11:50 a.m.
Optimizing Medical Management Before, During, After, and in the Absence of Surgical Reassignment
Optimizing Medical Management Before, During, After, and in the Absence of Surgical Reassignment
Charles Moser, PhD, MD
11:50 a.m. - 12:00 p.m.
Communication Skills
Communication Skills
Bruce Kava, MD
Afternoon
12:00 p.m. - 01:30 p.m.
Industry Sponsored Lunch SymposiumLocation: Salon F
show program01:30 p.m. - 03:30 p.m.
Men’s Health Symposium, Part II - Erectile DysfunctionLocation: Salon EModerators: Jeffrey Albaugh, PhD, APRN, CUCNS & Ryan Terlecki , MD
01:30 p.m. - 01:50 p.m.
Workup: Pychogenic / Organic / Associated Conditions (CVD/OSA)
Workup: Pychogenic / Organic / Associated Conditions (CVD/OSA)
William Brant, MD
01:50 p.m. - 02:10 p.m.
Penile Doppler: Tips / Tricks / Techniques
Penile Doppler: Tips / Tricks / Techniques
Landon Trost, MD
02:10 p.m. - 02:25 p.m.
Intracavernosal Injections – Tips, Tricks, Non-medical Options (VED), Meds, Compounding, Oral Failures, ICI
Intracavernosal Injections – Tips, Tricks, Non-medical Options (VED), Meds, Compounding, Oral Failures, ICI
Tobias Kohler, MD, MPH
02:25 p.m. - 02:40 p.m.
Managing Patient Malfunction with Penile Prosthesis – Trouble Shooting Indwelling Devices
Managing Patient Malfunction with Penile Prosthesis – Trouble Shooting Indwelling Devices
Andrew Kramer, MD
02:40 p.m. - 03:00 p.m.
Billing / Coding
Billing / Coding
Edward Karpman, MD
03:00 p.m. - 03:30 p.m.
Q&A
Q&A
01:30 p.m. - 03:30 p.m.
Peyronie’s DiseaseLocation: Salon C+DModerators: Wayne Hellstrom, MD & Ira Sharlip, MD
01:30 p.m. - 01:45 p.m.
Updates in PD - Most noteworthy literature from 2016-2017
Updates in PD - Most noteworthy literature from 2016-2017
Amy Guise, MD
01:45 p.m. - 01:55 p.m.
#028: Increased Risk of Incident Cancer in men with Peyronie’s Disease: Analysis of United States Claims Data
#028: Increased Risk of Incident Cancer in men with Peyronie’s Disease: Analysis of United States Claims Data
Alexander Pastuszak, MD, PhD
01:55 p.m. - 02:05 p.m.
#029: What about the Partner? Factors Associated with Partner Dyspareunia in Men with Peyronie’s Disease
#029: What about the Partner? Factors Associated with Partner Dyspareunia in Men with Peyronie’s Disease
Y. Meng
02:05 p.m. - 02:23 p.m.
Debate: CCH Should be Considered First Line Therapy for PD - Pro
Debate: CCH Should be Considered First Line Therapy for PD - Pro
Martin Gelbard, MD
02:23 p.m. - 02:50 p.m.
Debate: CCH Should be Considered First Line Therapy for PD - Con
Debate: CCH Should be Considered First Line Therapy for PD - Con
Irwin Goldstein, MD
02:50 p.m. - 03:00 p.m.
#030: Comparison of Surgical Outcomes in Men with Peyronie’s Disease Who Have Severe Crescent Shaped Curvature Vs. Acute Severe Angulation: A Single Institutional Analysis of 240 Patients.
#030: Comparison of Surgical Outcomes in Men with Peyronie’s Disease Who Have Severe Crescent Shaped Curvature Vs. Acute Severe Angulation: A Single Institutional Analysis of 240 Patients.
A.C. Chow
03:00 p.m. - 03:10 p.m.
#031: Atypical Peyronies – A Common Clinical Population That Remains Unrecognized
#031: Atypical Peyronies – A Common Clinical Population That Remains Unrecognized
N. Punjani
03:10 p.m. - 03:30 p.m.
Role of Adjunctive Therapies in PD: Vacuum and Traction Devices
Role of Adjunctive Therapies in PD: Vacuum and Traction Devices
Wayne Hellstrom, MD
01:30 p.m. - 03:30 p.m.
Sexual Mental HealthLocation: Salon A+BModerators: Stanley Althof, PhD & Michael Perelman, PhD
01:30 p.m. - 01:45 p.m.
Updates in Sexual Mental Health – Most Noteworthy Literature from 2016-2017
Updates in Sexual Mental Health – Most Noteworthy Literature from 2016-2017
Christian Nelson, PhD
01:45 p.m. - 01:55 p.m.
#032: The Impact of Sexual Dysfunction on Sexual Relationships
#032: The Impact of Sexual Dysfunction on Sexual Relationships
M. Alom
01:55 p.m. - 02:05 p.m.
#033: Interrelation of Consumption of Internet Pornography to Sexual Addiction and Sexual Functions
#033: Interrelation of Consumption of Internet Pornography to Sexual Addiction and Sexual Functions
Kweon Sik Min, MD
02:05 p.m. - 02:15 p.m.
#034: Prospective Evaluation of Depression and Sleep Disorders in Patients Presenting to a Men’s Health Clinic
#034: Prospective Evaluation of Depression and Sleep Disorders in Patients Presenting to a Men’s Health Clinic
A. Walia
02:15 p.m. - 02:35 p.m.
Depression, Suicidality, Erectile Dysfunction, and 5ARIs
Depression, Suicidality, Erectile Dysfunction, and 5ARIs
Culley Carson III, MD
02:35 p.m. - 03:00 p.m.
Psychogenic ED – Diagnosis and Management Strategies - Panel Discussion
Psychogenic ED – Diagnosis and Management Strategies - Panel Discussion
Ronald Lewis, MD (moderator), Lawrence Hakim, MD, FACS, Christian Nelson, PhD, Michael Perelman, PhD & Jordan Rullo, PhD, LP
03:00 p.m. - 03:30 p.m.
Diminished Libido, Depression, and Relationship Distress: What He’s Really Trying to Tell You
Diminished Libido, Depression, and Relationship Distress: What He’s Really Trying to Tell You
Alan Shindel, MD
03:30 p.m. - 04:00 p.m.
Coffee BreakLocation: Salon H+I
04:00 p.m. - 05:00 p.m.
Men’s Health Symposium, Part III - Peyronie's DiseaseLocation: Salon EModerators: Lawrence Jenkins, MD, MBA & Anand Shridharani, MD
04:00 p.m. - 04:20 p.m.
Diagnosis and Workup
Diagnosis and Workup
Wayne Hellstrom, MD
04:20 p.m. - 04:40 p.m.
Medical Treatment—Practical Tips/Tricks for Getting Best Outcomes Possible with an Interlesional Injection Program
Medical Treatment—Practical Tips/Tricks for Getting Best Outcomes Possible with an Interlesional Injection Program
Martin Gelbard, MD
04:40 p.m. - 05:00 p.m.
Surgical Treatment – Who and When
Surgical Treatment – Who and When
Laurence Levine, MD, FACS
04:00 p.m. - 05:30 p.m.
AndrogensLocation: Salon C+DModerators: Abraham Morgentaler, MD & Alexander Pastuszak, MD, PhD
04:00 p.m. - 04:10 p.m.
Updates in Androgens – Most Noteworthy Literature from 2016-2017
Updates in Androgens – Most Noteworthy Literature from 2016-2017
Kelly Chiles, MD
04:10 p.m. - 04:25 p.m.
Testosterone and Cardiovascular Health: Friend or Foe? - T is Good for CV Health
Testosterone and Cardiovascular Health: Friend or Foe? - T is Good for CV Health
Mohit Khera, MD
04:25 p.m. - 04:40 p.m.
Testosterone and Cardiovascular Health: Friend or Foe? - T is Bad for CV Health
Testosterone and Cardiovascular Health: Friend or Foe? - T is Bad for CV Health
Serge Carrier, MD
04:40 p.m. - 04:50 p.m.
#035: A Pilot Study: Is the Second Morning Sample of Total Testosterone Level Really Necessary for Diagnosis?
#035: A Pilot Study: Is the Second Morning Sample of Total Testosterone Level Really Necessary for Diagnosis?
R. Tan
04:50 p.m. - 05:00 p.m.
#036: Testosterone Recovery Profiles after Cessation of Androgen Deprivation Therapy (ADT)
#036: Testosterone Recovery Profiles after Cessation of Androgen Deprivation Therapy (ADT)
John Mulhall, MD
05:00 p.m. - 05:10 p.m.
#037: A Randomized Double Blinded Placebo Controlled Crossover Pilot Trial between Anastrozole and Clomiphene to Evaluate Improvement in Hypogonadal Symptoms and Erectile
#037: A Randomized Double Blinded Placebo Controlled Crossover Pilot Trial between Anastrozole and Clomiphene to Evaluate Improvement in Hypogonadal Symptoms and Erectile
J. Mahon
05:10 p.m. - 05:20 p.m.
Debate: Clomiphene Citrate Should be 1st Line for TDS - Pro
Debate: Clomiphene Citrate Should be 1st Line for TDS - Pro
Andrew McCullough, MD
05:20 p.m. - 05:30 p.m.
Debate: Clomiphene Citrate Should be 1st Line for TDS - Con
Debate: Clomiphene Citrate Should be 1st Line for TDS - Con
Bruce Redmon, MD
04:00 p.m. - 05:30 p.m.
Practice and EducationLocation: Salon A+BModerators: Amy Guise, MD & Run Wang, MD, FACS
04:00 p.m. - 04:15 p.m.
Common Methodological Errors and Statistical Interpretations: Can You Really Conclude That?
Common Methodological Errors and Statistical Interpretations: Can You Really Conclude That?
Ranjith Ramasamy, MD
04:15 p.m. - 04:25 p.m.
The 5 Most Common Errors in Failed Publications and How to Avoid Them
The 5 Most Common Errors in Failed Publications and How to Avoid Them
John Mulhall, MD
04:25 p.m. - 04:35 p.m.
#038: Formal Instruction Increases Medical Student Comfort Discussing Sexual Topics With Patients
#038: Formal Instruction Increases Medical Student Comfort Discussing Sexual Topics With Patients
R. Sosland
04:35 p.m. - 04:45 p.m.
#039: The Development of a Patient Reported Outcome Measure to Assess Sexual Impacts of Genital Psoriasis: GPSIS
#039: The Development of a Patient Reported Outcome Measure to Assess Sexual Impacts of Genital Psoriasis: GPSIS
R. Burge
04:45 p.m. - 05:05 p.m.
How to Make it Through a Lawsuit (or avoid one)
How to Make it Through a Lawsuit (or avoid one)
Glenn Dopf, LLM, JD
05:05 p.m. - 05:30 p.m.
Work-life Balance: A Lifetime of Experience of What Works and What Doesn’t - Moderated Panel of Significant Others of Well-known Andrology Leaders
Work-life Balance: A Lifetime of Experience of What Works and What Doesn’t - Moderated Panel of Significant Others of Well-known Andrology Leaders
Irwin Goldstein, MD (moderator), Tobias Kohler, MD, MPH (moderator), Ronald Lewis, MD (moderator), Rhonice Burnett, MA, MBA, Helena Christine & Judy Sharlip
05:00 p.m. - 05:30 p.m.
Men’s Health Symposium, Part IV - Ejaculatory DisordersLocation: Salon EModerators: Jeffrey Albaugh, PhD, APRN, CUCNS & Jason Jameson, MD
05:00 p.m. - 05:20 p.m.
Premature Ejaculation / Ejaculatory Dysfunction
Premature Ejaculation / Ejaculatory Dysfunction
Alan Shindel, MD
05:20 p.m. - 05:30 p.m.
Q&A
Q&A
Evening
05:30 p.m. - 06:15 p.m.
Residents ArenaLocation: Salon C+D
05:30 p.m. - 05:35 p.m.
#037: A Randomized Double Blinded Placebo Controlled Crossover Pilot Trial between Anastrozole and Clomiphene to Evaluate Improvement in Hypogonadal Symptoms and Erectile
#037: A Randomized Double Blinded Placebo Controlled Crossover Pilot Trial between Anastrozole and Clomiphene to Evaluate Improvement in Hypogonadal Symptoms and Erectile
J. Mahon
05:35 p.m. - 05:40 p.m.
#030: Comparison of Surgical Outcomes in Men with Peyronie’s Disease Who Have Severe Crescent Shaped Curvature Vs. Acute Severe Angulation: A Single Institutional Analysis of 240 Patients.
#030: Comparison of Surgical Outcomes in Men with Peyronie’s Disease Who Have Severe Crescent Shaped Curvature Vs. Acute Severe Angulation: A Single Institutional Analysis of 240 Patients.
A.C. Chow
05:40 p.m. - 05:45 p.m.
#029: What about the Partner? Factors Associated with Partner Dyspareunia in Men with Peyronie’s Disease
#029: What about the Partner? Factors Associated with Partner Dyspareunia in Men with Peyronie’s Disease
Y. Meng
05:45 p.m. - 05:50 p.m.
#022: Emerging Mechanic Failure and Complications Related to Ectopic Placement of Reservoir
#022: Emerging Mechanic Failure and Complications Related to Ectopic Placement of Reservoir
J. Clavell Hernandez
05:50 p.m. - 05:55 p.m.
#018: TNF-alpha Inhibition Improves Parasympathetic Nerve Function and is Associated with Altered Macrophage Infiltration of the Major Pelvic Ganglion following Nerve Injury
#018: TNF-alpha Inhibition Improves Parasympathetic Nerve Function and is Associated with Altered Macrophage Infiltration of the Major Pelvic Ganglion following Nerve Injury
Nikolai Sopko, MD, PhD
05:55 p.m. - 06:00 p.m.
#128: Sex Hormone Binding Globulin Independently Predicts Oligospermia in Male Fertility Patients
#128: Sex Hormone Binding Globulin Independently Predicts Oligospermia in Male Fertility Patients
J. Ring
06:00 p.m. - 06:05 p.m.
#031: Atypical Peyronies – A Common Clinical Population That Remains Unrecognized
#031: Atypical Peyronies – A Common Clinical Population That Remains Unrecognized
N. Punjani
06:05 p.m. - 06:10 p.m.
#038: Formal Instruction Increases Medical Student Comfort Discussing Sexual Topics With Patients
#038: Formal Instruction Increases Medical Student Comfort Discussing Sexual Topics With Patients
R. Sosland
06:15 p.m. - 07:15 p.m.
Young Clinician Mixer / Rising Stars ReceptionLocation: Conference Room 17+18
Sunday, October 29, 2017
Morning
07:45 a.m. - 09:00 a.m.
Take Home Messages (breakfast available)Location: Salon EModerators: Martin Gross, MD & Landon Trost, MD
08:00 a.m. - 08:15 a.m.
Basic Science
Basic Science
Justin La Favor, PhD
08:15 a.m. - 08:30 a.m.
Female Sexual Medicine
Female Sexual Medicine
Rachel Rubin, MD
08:30 a.m. - 08:45 a.m.
Erectile Dysfunction
Erectile Dysfunction
Casey McCraw, MD
08:45 a.m. - 09:00 a.m.
PD, Androgens, and Other Male Sexual Dysfunction
PD, Androgens, and Other Male Sexual Dysfunction
George Abdelsayed, MD
09:00 a.m. - 09:20 a.m.
Awards for Essays / Best AbstractsLocation: Salon E
09:20 a.m. - 10:00 a.m.
Top Overall Abstracts of MeetingLocation: Salon EModerator: Landon Trost, MD
09:20 a.m. - 09:24 a.m.
#016: Fidgetin-like 2, a Novel Microtubule Regulator, can be Targeted to Promote Nerve Regeneration and Improve Erectile Function after Cavernous Nerve Injury
#016: Fidgetin-like 2, a Novel Microtubule Regulator, can be Targeted to Promote Nerve Regeneration and Improve Erectile Function after Cavernous Nerve Injury
L. Baker
09:24 a.m. - 09:28 a.m.
#017: Differential Effects on MPG Neurons and Penile Vasculature after Conformal Prostate Radiation in Rats
#017: Differential Effects on MPG Neurons and Penile Vasculature after Conformal Prostate Radiation in Rats
M.R. Odom
09:28 a.m. - 09:32 a.m.
#020: Erectile Dysfunction Genomics (EDGE): A GWAS of Erectile Dysfunction in the Kaiser Permanente of Northern California (KPNC) Genetic Epidemiology Research on Aging (GERA) Cohort
#020: Erectile Dysfunction Genomics (EDGE): A GWAS of Erectile Dysfunction in the Kaiser Permanente of Northern California (KPNC) Genetic Epidemiology Research on Aging (GERA) Cohort
M.R. Palmer
09:32 a.m. - 09:36 a.m.
#006: Topical Abdominal Application of Curcumin-containing Nanoparticles Protects Erectile Function and Correlates with Corporal Expression of Inflammatory Markers (HO-1 and Nf- kB) in a Rat Model of Type-2-diabetes
#006: Topical Abdominal Application of Curcumin-containing Nanoparticles Protects Erectile Function and Correlates with Corporal Expression of Inflammatory Markers (HO-1 and Nf- kB) in a Rat Model of Type-2-diabetes
A. Draganski
09:36 a.m. - 09:40 a.m.
#007: The Effects of Local Delivery of Lipoic Acid and 4-Hydroxy-2,5,6-triaminopyrimidine Sulfate after Bilateral Nerve Crush Injury in the Rat Animal Model
#007: The Effects of Local Delivery of Lipoic Acid and 4-Hydroxy-2,5,6-triaminopyrimidine Sulfate after Bilateral Nerve Crush Injury in the Rat Animal Model
N.M. Haney
09:40 a.m. - 09:44 a.m.
#035: A Pilot Study: Is the Second Morning Sample of Total Testosterone Level Really Necessary for Diagnosis?
#035: A Pilot Study: Is the Second Morning Sample of Total Testosterone Level Really Necessary for Diagnosis?
R. Tan
09:44 a.m. - 09:48 a.m.
#036: Testosterone Recovery Profiles after Cessation of Androgen Deprivation Therapy (ADT)
#036: Testosterone Recovery Profiles after Cessation of Androgen Deprivation Therapy (ADT)
John Mulhall, MD
09:48 a.m. - 09:52 a.m.
#032: The Impact of Sexual Dysfunction on Sexual Relationships
#032: The Impact of Sexual Dysfunction on Sexual Relationships
M. Alom
09:52 a.m. - 09:56 a.m.
#132: Initial Experience with Testosterone Therapy in Selected Men with Advanced or Metastatic Prostate Cancer
#132: Initial Experience with Testosterone Therapy in Selected Men with Advanced or Metastatic Prostate Cancer
Abraham Morgentaler, MD
09:56 a.m. - 10:00 a.m.
#010: Simulation of Mid-Urethral Incontinence Sling Surgery Using Cadavers: Impact on Innervation and Glandular Tissue
#010: Simulation of Mid-Urethral Incontinence Sling Surgery Using Cadavers: Impact on Innervation and Glandular Tissue
D. Gaudet
10:00 a.m. - 12:00 p.m.
SMSNA/SSMR SymposiumLocation: Salon EModerators: Joseph Alukal, MD & Mohit Khera, MD
10:00 a.m. - 10:30 a.m.
Is Vasectomy Benign?
Is Vasectomy Benign?
Joseph Alukal, MD
10:30 a.m. - 11:00 a.m.
AUA Vasectomy Guidelines Review
AUA Vasectomy Guidelines Review
Stanton Honig, MD
11:00 a.m. - 11:30 a.m.
Impact of Shift Work on Men’s Sexual and Reproductive Health
Impact of Shift Work on Men’s Sexual and Reproductive Health
Alexander Pastuszak, MD, PhD
11:30 a.m. - 12:00 p.m.
Management of Hormonal Dysfunction in the Infertile Male Patient
Management of Hormonal Dysfunction in the Infertile Male Patient
Thomas Walsh, MD, MS
Unmoderated Posters
Unmoderated Posters
Unmoderated Posters
#301: One-Year Hematologic Safety of Natesto (testosterone) Nasal Gel in Men with Hypogonadism
M. Guidry
#302: Safety of Testosterone Therapy in Octogenarians: An Increasingly Important Demographic in 2017
Y. Krakowsky
#303: Risk of Polycythemia after Testosterone Replacement Therapy: Aveed vs. Testopel
Y.K. Khandwala
#304: Summative Usability Evaluation of the SCTE-AI, a Novel, Prefilled, Autoinjector for Subcutaneous Testosterone Administration
J. Kaminetsky
#306: Penile Wobble Effect: Proximal Corporal Dilatation as a Cause of Penile Prosthesis Failure
E. Rajih
#307: Penile Rehabilitation Therapy Following Radical Prostatectomy: A Meta-analysis
C. Liu
#308: Preservation of Baseline Erectile Function in Radiotherapy Patients using Phosphodiesterase Type 5 Inhibitors
John Mulhall, MD
#309: Critical Analysis of Penile Duplex Doppler Ultrasound (PDDU) in Erectile Dysfunction (ED): Technical And Interpretation Deficiencies
John Mulhall, MD
#310: Clinical Improvements in Erectile Function and Mood in Hypogonadal Men Treated with 4.5% Nasal Testosterone Gel (Natesto)
L. Lipshultz
#311: Novel Penile Ultrasound Technique to Explain Mechanism of Erectile Dysfunction (ED) in Young Patients using Finasteride for Androgenic Alopecia
Rachel Rubin, MD
#312: A Randomized, Controlled, Three-Arm Study To Define The Utility Of PDE5 Inhibitors And Intracavernosal Injections In The Radical Prostatectomy Population
John Mulhall, MD
#313: Improving Diagnostic Capture of Organic ED on Ultrasound: Corporal Heterogeneity Grading to Assess Penile Fibrosis
A. Winter
#314: Regret with Penile Prosthesis: Characteristics and Factors of Dissatisfied Men
M. Alom
#316: Factors Associated with Chronic Pain Following Penile Prosthesis Implantation
R. Avant
#318: Pattern of Surgical Care of Patients with Erectile Dysfunction: Pooled Analysis from two Prospective Population-based Registry
Gerard Henry, MD
#321: Sterile Surgical Preparation Gone Wrong: Iodine Allergy Mimicking Early Prosthesis Infection
D. Belew
#322: Safety, Efficacy, and Satisfaction of Penile Implant Surgery following Radical Cystectomy and Urinary Diversion
D.M. Lopategui
#323: Selective Venous Embolization for Treatment of Venogenic Erectile Dysfunction
M.W. Kemper
#324: An Initial Description of Adult Men With Progression Of Chordee To A Fibrotic Disorder Of The Tunica Albuginea
M.R. Farrell
#325: Correlation Between Penile Deformity, Patient Bother, and Perceived Partner Bother in Men with Peyronie's Disease
P.V. Bach
#326: Comparative Analysis Of The Natural History Of De Novo Peyronie’s Disease Versus Post-Radical Prostatectomy Peyronie’s Disease
J.S. Sullivan
#327: Impact of Collagenase Clostridium Histolyticum on Erectile Function in Peyronie’s Disease Patients
R. Bole
#328: Ultrasonographic Changes to Cavernosal Tissue in Men with New-Onset Erectile Dysfunction following Penile Plication Surgery
A. Winter
#329: A Simple Novel Surgical Technique for Penile Elongation; Compensation for Tunical Plication in Peyronie’s Disease
Du Geon Moon, MD
#330: Residual Curvature after Penile Prosthesis: The Role of Peyronie’s Patch Grafts
J.A. Beilan
#331: Does pre-operative Evaluation of Patient with Peyronie's Disease Correspond to Intra-operative Findings and Need for Adjunctive Straightening Procedures at Time of IPP Placement?
D. Hawksworth
#332: Autologous Dermal Tissue Grafting for Peyronie’s Disease with Large Tunica Albuginea Defects
Koichi Nagao, MD, PhD
#333: Art of the Curve: Utilizing Pipe Cleaners as a Patient Home Assessment Tool to Measure Changes in Curvature after Intralesional Injection of Verapamil (ILIV) for Peyronie’s Disease
M. Mendez
#334: Post Priapism PROPPER Data Shows Good Satisfaction and Functional Outcomes
J. Wallen
#335: Implant Selection Patterns and Reoperation Rates amongst Solid Organ Transplant Recipients that Underwent Penile Prosthesis Surgery
D. Asafu-Adjei
#336: Nationwide Utilization of Reconstructive Urological Procedures to Mitigate Sexual and Urinary Complications Following Radical Prostatectomy
L. Aliperti
#337: Comparison of Correlated Comorbidities in Male and Female Sexual Dysfunction: Findings from the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)
A. Polland
#339: Testosterone Replacement Therapy Contributes to Improving Lower Urinary Tract Symptoms in Men with Testosterone Deficiency Syndrome
H.S. Shin
#340: Safety of Testosterone Therapy in a Large Clinical Cohort of Men with Prostate Cancer
Abraham Morgentaler, MD